CCL5 and HIV infectious disease: The delay of CCL5 protein production post IFNβ treatment may explain why neutralizing antibodies against CCL5 did not abrogate the protective effects of IFNβ, and may indicate that IFNβ-mediated induction of CCL4 could play an important role in neuronal protection in acute HIV-infection.